Alendronate reaches U.S. market for osteoporosis, Paget's disease.
D019386:Alendronate; D004164:Diphosphonates / Q000493:pharmacokinetics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D014481:United States
D004164:Diphosphonates; D019386:Alendronate